Results 51 to 60 of about 18,233 (306)

EARLY DEGENERATED BIOPROSTHETIC MITRAL VALVE [PDF]

open access: yesRomanian Journal of Pediatrics, 2014
Mitral valve prolapse (MVP) is fairly common in children, often being randomly found in asymptomatic, as well as in symptomatic patients with conjunctive tissue diseases (CTD). The authors report the case of an 11-yearold girl, diagnosed at the age of 6
Irina-Mihaela Ciomaga   +5 more
doaj   +1 more source

Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteriaCentral MessagePerspective

open access: yesJTCVS Open, 2022
Objectives: The Carpentier-Edwards Perimount Magna Ease (Edwards Lifesciences) pericardial bioprosthesis has demonstrated satisfying hemodynamics at midterm follow-up, but its durability remains unclear.
Stéphane Kermen, MD   +6 more
doaj  

Hemodynamic and physical performance during maximal exercise in patients with an aortic bioprosthetic valve Comparison of stentless versus stented bioprostheses [PDF]

open access: yes, 1999
OBJECTIVESThe objective of this study was to compare stentless bioprostheses with stented bioprostheses with regard to their hemodynamic behavior during exercise.BACKGROUNDStentless aortic bioprostheses have better hemodynamic performances at rest than ...
Cartier, Paul   +5 more
core   +1 more source

Restoration of a Stuck Leaflet

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Severe aortic regurgitation (AR) for a leaflet malfunction after transcatheter aortic valve implantation (TAVI) is a dreadful complication that can lead even to cardiogenic shock. New valve's design has reduced the rate of paravalvular regurgitation, however central regurgitation is still a challenging complication.
Elisa Tomarelli   +3 more
wiley   +1 more source

Bridging aortic valve surgery to 21st century. what can a surgeon do [PDF]

open access: yes, 2019
Aortic valve stenosis is the most clinically relevant valvular heart disease in the elderlies. Surgical aortic valve replacement (SAVR) represented, for decades, the standard of care for the treatment of severe aortic stenosis.
Barretta, Antonio   +13 more
core   +1 more source

Long‐Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 5, Page 1161-1170, April 1, 2025.
ABSTRACT Background Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐
Juri Iwata   +15 more
wiley   +1 more source

Normally and abnormally functioning left-sided porcine bioprosthetic valves after long-term implantation in patients: Distinct spectra of histologic and histochemical changes [PDF]

open access: yes, 1984
This morphologic study (X-ray examination of gross specimens, histologic study and histochemical staining) compares two groups of explanted left-sided biopros-thetic valves: group 1,6 valves with normal cusp function and group II, 10 valves with ...
Deuvaert, Frank   +5 more
core   +1 more source

Percutaneous Pulmonary Valve Implantation In Native Right Ventricular Outflow Tract Using Myval™ Without Pre‐Stenting

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Percutaneous pulmonary valve implantation was introduced two decades ago as a low‐risk alternative for patients previously operated with conduits presenting RVOT dysfunction. Recently, Sapien valve was approved for use in the pulmonary position but this valve cannot be used for RVOT larger than 29 mm.
João Luiz Langer Manica   +13 more
wiley   +1 more source

Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up [PDF]

open access: yes, 2016
Transcatheter mitral valve implantation for mitral valve regurgitation is in the very early phase of development because of challenging anatomy and device dimensions.
Cammalleri, V   +8 more
core   +1 more source

Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Bioprosthetic heart valves (BHVs) largely circumvent the need for long‐term anticoagulation compared with mechanical valves but are increasingly susceptible to deterioration and reduced durability with reoperation rates of ≈10% and 30% at 10 and 15 years,
Matteo Marro   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy